Showing 8,921 - 8,940 results of 39,308 for search '(( 50 ((((mean decrease) OR (we decrease))) OR (a decrease)) ) OR ( 5 non decrease ))', query time: 1.32s Refine Results
  1. 8921

    Data Sheet 1_Gender differences in the association between sleep duration and diabetes in Chinese adults.docx by Haiyan Yu (356393)

    Published 2025
    “…</p>Results<p>During the follow-up period from 2004 to 2015, there were 222 new cases of diabetes in men (5.34 per 1000 person-years) and 234 cases in women (5.26 per 1000 person-years) participants had newly developed diabetes. …”
  2. 8922

    Data_Sheet_1_A Multimodal Fusion Analysis of Pretreatment Anatomical and Functional Cortical Abnormalities in Responsive and Non-responsive Schizophrenia.docx by Chenyang Yao (7344434)

    Published 2021
    “…Based on the decrease in Positive and Negative Syndrome Scale scores from baseline to the 1-year follow-up, FES patients were divided into a responder group (RG) and a non-responder group (NRG). …”
  3. 8923
  4. 8924

    Solid State and Aqueous Solution Characterization of Rectangular Tetranuclear V<sup>IV/V</sup>-<i>p</i>-Semiquinonate/Hydroquinonate Complexes Exhibiting a Proton Induced Electron... by Chryssoula Drouza (1406464)

    Published 2008
    “…Reaction of the non-innocent dinucleating ligand 2,5-bis[N,N-bis(carboxymethyl) aminomethyl]hydroquinone (H<sub>6</sub>bicah) with VO<sup>2+</sup> and VO<sub>4</sub><sup>3−</sup> salts in water in the pH range 2 to 4.5 provides a series of novel tetranuclear V<sup>IV</sup> and/or V<sup>V</sup> macrocycles with the main core consisting of the anions [V<sup>V</sup><sub>4</sub>O<sub>4</sub>(μ-O)<sub>2</sub>(μ-bicah)<sub>2</sub>]<sup>4−</sup> isolated at pH = 2.5 and [V<sup>IV</sup><sub>2</sub>V<sup>V</sup><sub>2</sub>O<sub>4</sub>(μ-O)<sub>2</sub>(μ-bicas)(μ-bicah)]<sup>5−</sup> and [V<sup>IV</sup><sub>4</sub>O<sub>4</sub>(μ-O)<sub>2</sub>(μ-bicas)<sub>2</sub>]<sup>6−</sup> isolated at pH = 4.5 (bicas<sup>•5−</sup> = 2,5-bis[N,N-bis(carboxymethyl) aminomethyl]-<i>p</i>-semiquinonate), whereas at pH = 2 the dinuclear [(V<sup>IV</sup>O)<sub>2</sub>(OH<sub>2</sub>)<sub>2</sub>(μ-bicah)]<sup>2−</sup> was obtained. …”
  5. 8925

    Design of <i>N</i>‑Benzoxaborole Benzofuran GSK8175Optimization of Human Pharmacokinetics Inspired by Metabolites of a Failed Clinical HCV Inhibitor by Pek Y. Chong (1833568)

    Published 2019
    “…We previously described the discovery of GSK5852 (<b>1</b>), a non-nucleoside polymerase (NS5B) inhibitor of hepatitis C virus (HCV), in which an <i>N</i>-benzyl boronic acid was essential for potent antiviral activity. …”
  6. 8926

    Table5_MiR-29b-3p Inhibits Migration and Invasion of Papillary Thyroid Carcinoma by Downregulating COL1A1 and COL5A1.xls by Congjun Wang (1267932)

    Published 2025
    “…</p>Results<p>Our findings revealed that miR-29b-3p proved much more regulated downward in PTC tissue specimens than in adjacent non-cancerous tissues. Meanwhile, decreased expression of miR-29b-3p was strongly related to the TNM stage of PTC patients (p<0.001), while overexpression of miR-29b-3p in PTC cells suppressed cellular migration, invasion, proliferation, and EMT. …”
  7. 8927

    Table_5_MiR-29b-3p Inhibits Migration and Invasion of Papillary Thyroid Carcinoma by Downregulating COL1A1 and COL5A1.xls by Congjun Wang (1267932)

    Published 2022
    “…</p>Results<p>Our findings revealed that miR-29b-3p proved much more regulated downward in PTC tissue specimens than in adjacent non-cancerous tissues. Meanwhile, decreased expression of miR-29b-3p was strongly related to the TNM stage of PTC patients (p<0.001), while overexpression of miR-29b-3p in PTC cells suppressed cellular migration, invasion, proliferation, and EMT. …”
  8. 8928
  9. 8929
  10. 8930

    Table 1_Trends and forecasts of vitamin A deficiency burden in China, 1990–2035.docx by Zhongming Ye (21865547)

    Published 2025
    “…However, DALYs rebounded among those aged 50–74 years. Significant age and sex disparities exist. …”
  11. 8931
  12. 8932

    Analgesic prescriptions received by patients before commencing the BOA model of care for osteoarthritis: a Swedish national registry study with matched reference and clinical guide... by Allan Abbott (6032138)

    Published 2021
    “…Since guideline publication, the proportion of the OA cohort having no dispensed prescription analgesics prior to non-pharmacological primary care intervention concordantly increased by 5.0% (95% CI 4.2–5.9). …”
  13. 8933

    Table 1_Eculizumab is efficacious and safe in pediatric patients with various forms of hemolytic uremic syndrome: a retrospective clinical experience of a tertiary center.docx by Naama Lax (20998004)

    Published 2025
    “…We evaluated its efficacy and safety in pediatric patients with TMA sub-types: atypical HUS (aHUS), Shiga toxin-producing Escherichia coli (STEC)-HUS, and transplant-associated TMA (TA-TMA).…”
  14. 8934
  15. 8935

    RhoC dictates the behavior and abundance of SUM149 and MCF-10A BCSCs. by Devin T. Rosenthal (148780)

    Published 2012
    “…(<b>D</b>) In addition to modifying the behavior of ALDH (+) cells, RhoC expression also alters the abundance of ALDH (+) BCSCs within a cell line. The relative number of ALDH (+) cells within the SUM149 population decreases by over 50% in SUM149 shRhoC compared to SUM149 scrambled cells and is doubled in MCF-10A G14V compared to MCF-10A vec cells. …”
  16. 8936
  17. 8937
  18. 8938

    AR negative triple negative or “quadruple negative” breast cancers in African American women have an enriched basal and immune signature by Melissa Davis (3522224)

    Published 2018
    “…AR-negative patients have a (66.60; 95% CI, 32–146) odds ratio of being basal-like compared to other PAM50 subtypes, and this is associated with an increased time to progression and decreased overall survival. …”
  19. 8939
  20. 8940

    Supplementary Material for: Daily Habit of Water Intake in Patients with Cerebral Infarction before its Onset; Comparison with a Healthy Population: A Cross-Sectional Study by Nishikawa T. (3272898)

    Published 2019
    “…The mean NAD intake was 1,702.5 ± 670.2 mL in the “increased” group, 1,494.2 ± 611.2 mL in the “unchanged” group, 1,268.0 ± 596.1 mL in the “decreased” group, and 1,720.6 ± 686.0 mL in the “healthy” group. …”